Big Pharma’s Big Lie: The Truth About Innovation & Drug Prices

Big Pharma’s innovation argument just does not stand up to scrutiny. We can’t allow drug corporations to continue to hide behind their threat that if we do anything to curb the industry’s unilateral pricing power, innovation will die. The truth is that if we don’t do something to restore the balance between pricing to reward innovation while ensuring affordability and accessibility, there is no doubt people will die because they cannot afford the existing drugs they need right now. And we won’t be able to afford the new drugs to come.

Patients For Affordable Drugs

3 February 2021

External Link